FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221036792> ?p ?o ?g. }

• W4221036792 endingPage "1415" @default.
• W4221036792 startingPage "1408" @default.
• W4221036792 abstract "To investigate the mechanism for increased ketogenesis following treatment with the SGLT2 inhibitor dapagliflozin in people with type 2 diabetes.The design was a double-blind, placebo-controlled, crossover study with a 4-week washout period. Participants received dapagliflozin or placebo in random order for 4 weeks. After each treatment, they ingested 30 mL of olive oil containing [U-13C]palmitate to measure ketogenesis, with blood sampling for 480 min. Stable isotopes of glucose and glycerol were infused to measure glucose flux and lipolysis, respectively, at 450-480 min.Glucose excretion rate was higher and peripheral glucose uptake lower with dapagliflozin than placebo. Plasma β-hydroxybutyrate (BOHB) concentrations and [13C2]BOHB concentrations were higher and glucose concentrations lower with dapagliflozin than placebo. Nonesterified fatty acids (NEFAs) were higher with dapagliflozin at 300 and 420 min, but lipolysis at 450-480 min was not different. Triacylglycerol at all time points and endogenous glucose production rate at 450-480 min were not different between treatments.The increase in ketone enrichment from the ingested palmitic acid tracer suggests that meal-derived fatty acids contribute to the increase in ketones during treatment with dapagliflozin. The increase in BOHB concentration with dapagliflozin occurred with only minimal changes in plasma NEFA concentration and no change in lipolysis. This finding suggests a metabolic switch to increase ketogenesis within the liver." @default.
• W4221036792 created "2022-04-03" @default.
• W4221036792 creator A5001369917 @default.
• W4221036792 creator A5014024896 @default.
• W4221036792 creator A5034745495 @default.
• W4221036792 creator A5049185876 @default.
• W4221036792 creator A5062295949 @default.
• W4221036792 creator A5067547623 @default.
• W4221036792 creator A5072994309 @default.
• W4221036792 creator A5079044250 @default.
• W4221036792 creator A5082184915 @default.
• W4221036792 creator A5083686114 @default.
• W4221036792 creator A5084593004 @default.
• W4221036792 date "2022-03-21" @default.
• W4221036792 modified "2023-09-27" @default.
• W4221036792 title "The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes" @default.
• W4221036792 cites W1526786066 @default.
• W4221036792 cites W1953794210 @default.
• W4221036792 cites W1957004156 @default.
• W4221036792 cites W2008443217 @default.
• W4221036792 cites W2018893256 @default.
• W4221036792 cites W2048565142 @default.
• W4221036792 cites W2081510795 @default.
• W4221036792 cites W2082546664 @default.
• W4221036792 cites W2082600035 @default.
• W4221036792 cites W2113507924 @default.
• W4221036792 cites W2114031829 @default.
• W4221036792 cites W2114276479 @default.
• W4221036792 cites W2122077393 @default.
• W4221036792 cites W2126260552 @default.
• W4221036792 cites W2156690149 @default.
• W4221036792 cites W2157405334 @default.
• W4221036792 cites W2189728293 @default.
• W4221036792 cites W2196957880 @default.
• W4221036792 cites W2341611738 @default.
• W4221036792 cites W2576291926 @default.
• W4221036792 cites W2604517254 @default.
• W4221036792 cites W2749078254 @default.
• W4221036792 cites W2909093692 @default.
• W4221036792 cites W2913004143 @default.
• W4221036792 cites W2945855256 @default.
• W4221036792 cites W2986499379 @default.
• W4221036792 cites W2990477008 @default.
• W4221036792 cites W3003663516 @default.
• W4221036792 cites W3004982267 @default.
• W4221036792 cites W3036311249 @default.
• W4221036792 doi "https://doi.org/10.2337/dc21-2043" @default.
• W4221036792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35312749" @default.
• W4221036792 hasPublicationYear "2022" @default.
• W4221036792 type Work @default.
• W4221036792 citedByCount "5" @default.
• W4221036792 countsByYear W42210367922022 @default.
• W4221036792 countsByYear W42210367922023 @default.
• W4221036792 crossrefType "journal-article" @default.
• W4221036792 hasAuthorship W4221036792A5001369917 @default.
• W4221036792 hasAuthorship W4221036792A5014024896 @default.
• W4221036792 hasAuthorship W4221036792A5034745495 @default.
• W4221036792 hasAuthorship W4221036792A5049185876 @default.
• W4221036792 hasAuthorship W4221036792A5062295949 @default.
• W4221036792 hasAuthorship W4221036792A5067547623 @default.
• W4221036792 hasAuthorship W4221036792A5072994309 @default.
• W4221036792 hasAuthorship W4221036792A5079044250 @default.
• W4221036792 hasAuthorship W4221036792A5082184915 @default.
• W4221036792 hasAuthorship W4221036792A5083686114 @default.
• W4221036792 hasAuthorship W4221036792A5084593004 @default.
• W4221036792 hasBestOaLocation W42210367921 @default.
• W4221036792 hasConcept C10146269 @default.
• W4221036792 hasConcept C126322002 @default.
• W4221036792 hasConcept C134018914 @default.
• W4221036792 hasConcept C140985366 @default.
• W4221036792 hasConcept C171089720 @default.
• W4221036792 hasConcept C185592680 @default.
• W4221036792 hasConcept C2777180221 @default.
• W4221036792 hasConcept C2777422806 @default.
• W4221036792 hasConcept C2778563252 @default.
• W4221036792 hasConcept C2779306644 @default.
• W4221036792 hasConcept C31532488 @default.
• W4221036792 hasConcept C555293320 @default.
• W4221036792 hasConcept C62231903 @default.
• W4221036792 hasConcept C71924100 @default.
• W4221036792 hasConcept C84693403 @default.
• W4221036792 hasConceptScore W4221036792C10146269 @default.
• W4221036792 hasConceptScore W4221036792C126322002 @default.
• W4221036792 hasConceptScore W4221036792C134018914 @default.
• W4221036792 hasConceptScore W4221036792C140985366 @default.
• W4221036792 hasConceptScore W4221036792C171089720 @default.
• W4221036792 hasConceptScore W4221036792C185592680 @default.
• W4221036792 hasConceptScore W4221036792C2777180221 @default.
• W4221036792 hasConceptScore W4221036792C2777422806 @default.
• W4221036792 hasConceptScore W4221036792C2778563252 @default.
• W4221036792 hasConceptScore W4221036792C2779306644 @default.
• W4221036792 hasConceptScore W4221036792C31532488 @default.
• W4221036792 hasConceptScore W4221036792C555293320 @default.
• W4221036792 hasConceptScore W4221036792C62231903 @default.
• W4221036792 hasConceptScore W4221036792C71924100 @default.
• W4221036792 hasConceptScore W4221036792C84693403 @default.
• W4221036792 hasIssue "6" @default.
• W4221036792 hasLocation W42210367921 @default.

• next